A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61K 47/30 (2006.01) A61K 47/44 (2006.01) A61P 9/10 (2006.01) A61P 35/00 (2006.01) C07H 21/02 (2006.01) G01N 33/50 (2006.01) C12N 15/88 (2006.01)
Patent
CA 2535449
This invention discloses a method for preparing a complex comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with a Non- Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further discloses Complexes comprising one or more VEGF Nucleic Acid Ligands in association with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further includes a Lipid construct comprising a VEGF Nucleic Acid Ligand or Complex and methods for making the same.
Gold Larry
Janjic Nebojsa
Schmidt Paul G.
Vargeese Chandra
Willis Michael
Gilead Sciences Inc.
Sim & Mcburney
LandOfFree
Vascular endothelial growth factor (vegf) nucleic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vascular endothelial growth factor (vegf) nucleic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vascular endothelial growth factor (vegf) nucleic acid... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1681253